SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction

The SU5416 combined with hypoxia (SuHx) rat model features angio-obliterative pulmonary hypertension resembling human pulmonary arterial hypertension. Despite increasing use of this model, a comprehensive haemodynamic characterisation in conscious rats has not been reported. We used telemetry to characterise haemodynamic responses in SuHx rats and associated these with serial histology. Right ventricular systolic pressure (RVSP) increased to a mean±sd of 106±7 mmHg in response to SuHx and decreased but remained elevated at 72±8 mmHg upon return to normoxia. Hypoxia-only exposed rats showed a similar initial increase in RVSP, a lower maximum RVSP and near-normalisation of RVSP during subsequent normoxia. Progressive vascular remodelling consisted of a four-fold increase in intima thickness, while only minimal changes in media thickness were found. The circadian range in RVSP provided an accurate longitudinal estimate of vascular remodelling. In conclusion, in SuHx rats, re-exposure to normoxia leads to a partial decrease in pulmonary artery pressure, with persisting hypertension and pulmonary vascular remodelling characterised by progressive intima obstruction. Telemetry studies can facilitate preclinical studies to further improve our understanding of drug actions in PAH http://ow.ly/uXhjf

[1]  A. Alzoubi,et al.  Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats. , 2014, American journal of physiology. Heart and circulatory physiology.

[2]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[3]  M. Humbert,et al.  Copper dependence of angioproliferation in pulmonary arterial hypertension in rats and humans. , 2012, American journal of respiratory cell and molecular biology.

[4]  C. Mazer,et al.  Response of the Renal Inner Medulla to Hypoxia: Possible Defense Mechanisms , 2012, Nephron Physiology.

[5]  I. Fridolin,et al.  Utilization of UV Absorbance for Estimation of Phosphate Elimination during Hemodiafiltration , 2012, Nephron Clinical Practice.

[6]  L. Farkas,et al.  New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis , 2012, Pulmonary circulation.

[7]  S. Groshong,et al.  Modern age pathology of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[8]  L. Farkas,et al.  Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats , 2012, European Respiratory Journal.

[9]  D. Conrad,et al.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[10]  N. Voelkel,et al.  Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. , 2010, American journal of respiratory and critical care medicine.

[11]  N. Westerhof,et al.  The arterial load in pulmonary hypertension , 2010, European Respiratory Review.

[12]  N. Voelkel,et al.  Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension , 2010, Circulation.

[13]  Kurt R Stenmark,et al.  Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[14]  C. Long,et al.  Chronic Pulmonary Artery Pressure Elevation Is Insufficient to Explain Right Heart Failure , 2009, Circulation.

[15]  W. Paulus,et al.  A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research , 2007, Pflügers Archiv - European Journal of Physiology.

[16]  N. Voelkel,et al.  Rho Kinase-Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in Rats , 2007, Circulation research.

[17]  N. Voelkel,et al.  Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[18]  N. Voelkel,et al.  Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  T. Kurtz,et al.  Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Dyck,et al.  Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis , 2004, Circulation research.

[21]  Penny Hawkins,et al.  Refinements in telemetry procedures: Seventh report of BVAAWF/FRAME/RSPCA/UFAW Joint Working Group on Refinement, Part A , 2003, Laboratory animals.

[22]  P. Hirth,et al.  Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Wei Zhang,et al.  Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. , 1997, The American journal of pathology.

[24]  L. Reid,et al.  Normal structure and dimensions of the pulmonary arteries in the rat. , 1978, Journal of anatomy.